'Neuroendocrine tumor' presentation slideshows

613 views • 33 slides

Welcome to TODAYS CME

Welcome to TODAYS CME. Neuroendocrine Tumor(carcinoid) of stomach : A case report and update. Dr. Md. Rashedul Islam MD(Thesis Part Student) Department of Medical Oncology National Institute of Cancer Research & Hospital.

329 views • 32 slides

ECTOPIC CUSHING &NET

ECTOPIC CUSHING &NET. CLASSIFICATION. RESULTS. 86 to 94% of patients did not respond to CRH or dexamethasone suppression test. 66 of 67 had negative IPSS. Nonthymic carcinoids took longest to localize.

284 views • 27 slides

A Large Scale evaluation of SNP associations with Sporadic Neuroendocrine Tumors

A Large Scale evaluation of SNP associations with Sporadic Neuroendocrine Tumors. Monica Ter-Minassian, ScD Harvard School of Public Health. Objective. Determine genetic & other risk factors associated with sporadic neuroendocrine tumor risk

338 views • 19 slides

Scientific collaborators

In Situ Detection of Chromogranin A (CgA) Released from Living Neuron Using Single-Walled Carbon Nanotube Field Effect Transistors C. C. Tsai ( ??? ) Institute of Atomic and Molecular Sciences, Academia Sinica 2006-07-27. Scientific collaborators.

348 views • 19 slides

Global Neuroendocrine Tumor Treatment Market

Incidence and prevalence of neuroendocrine tumor is steadily rising, mainly due Multiple endocrine neoplasia type 1 (MEN1), Multiple endocrine neoplasia type 2 (MEN2), Neurofibromatosis type 1 (NF1), Von Hippel-Lindau syndrome (VHL) and Tuberous sclerosis complex (TSC) disease in the U.S. Moreover, based on a study published in the JAMA Oncology Journal, survival rate for all neuroendocrine tumor treatment have improved, especially for distant-stage gastrointestinal neuroendocrine tumor treatment and pancreatic neuroendocrine tumor treatment. This is mainly attributed to improved outcomes of availability of better therapies and early diagnosis. Introduction of new therapies and extended indications for approved drugs would benefit the growth of neuroendocrine tumor treatment market in North America and in turn is expected to significantly fuel growth of the global market. U.S. is the largest market for NET, in terms of revenue. No specific data is available regarding incidence of neuroendocrine tumors in Canada.

205 views • 8 slides

Research Insights on Global Somatostatin Analogs Market Size, Growth and Forecast to 2024

The global somatostatin analogs market size was valued at USD 2,166 million in 2014 and is expected to witness a significant growth, pertaining to the rise in the prevalence of acromegaly and neuroendocrine tumors coupled with the rising investments in R&D activities.

98 views • 8 slides

Neuroendocrine Tumor Treatment Market Witness Considerable Growth To 2025

The global neuroendocrine tumor treatment market was valued at US$ 1,197.3 million in 2015 and is expected to witness a CAGR of 10.5% By 2025

46 views • 3 slides

Metropolis Healthcare Ltd in Anand Vihar

Metropolis Healthcare Ltd is a diagnostic lab in Anand Vihar, Delhi. View details tests costs, labs timings, address and contact labs directly on Lybrate.com | Lybrate

36 views • 1 slides